1Ferrari R, Chiariello M, Nicolosi GL, et al. Effects of angio tensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized perindopril and remodeling in elderly with acute myo cardial infarction study [J]. Arch Intern Med, 2006, 166(3) : 659-666.
2Bolterman RJ, Manriquez MC, Ruiz MCO, et al. Effects of captopril on the renin angiotensin system, oxidative Stress, and endothelin in normal and hypertensive rats[J]. Hypertension, 2005,46: 943-947.
3Solomon SD, Skali H, Anavekar NS, et al. Changes in yen tricular size and function in patients treated with valsartan captopril, or both after myocardial infarction [J]. Circulation 2005, 111: 3411-3419.
4Kaur K, Sharma AK, Singal PK. Significance of changes in TNF-α and IL-10 levels in the progression of heart failure subsequent to myocardial infarction[J]. Am J Physiol Heart Circ Physiol, 2006, 291: 106-113.
5陈灏珠译.心脏病学[M].5版,北京:人民卫生出版社,2001:1084-1085.
6lee Goldman & Dennis Ausiello. Cecil Medicine E M]. 23rd ed. Amsterdam: Saunders Elsevier, 2008.
7Wang JB, Guan J, Shen J, et al. Insulin increases shedding of syndecan-1 in the serum of patients with 2 diabetes mellitus E J ] . Diab Res Clin Prac, 2009,86 (2) : 83 -88.
8Wang JB, Zhang YJ, Zhang Y, et al. Negatie correl- ation between serum syndecan-1 and apolipoprotein A1 in patients with type2 diabetes mellitus [ J 1. Acta Diabetol, 2013,50(2) : 111 - 115.
9Wang JB, Tian CW, Guo CM, et al. Increased leavel of soluble syndecan-1 in the subretinal fulid and the vitreous of eyes with rhegmatogenous retinal detachment[J]- Curr Eye Res, 2008,33(1) : 101 - 107.
10Vanhoutte D, Schellings MW, Gotte M, et al. Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction : J 1- Circulation,2007,115 (4) : 475 - 482.
